The transition from normal tissue to cancerous tissue seems to have a more pronounced impact on the transcription of KRAS4a compared to KRAS4b, particularly in colon, rectal, lung, and pancreatic cancers. Here, KRAS is linked to familial pancreatic carcinoma.